18.04.2008 22:40:00

Wright Medical To Be Featured In Fifth Season of John Ratzenberger's Made In America on the Travel Channel

Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic manufacturer, is pleased to announce that it will be a featured company during the fifth season of the popular Travel Channel show, John Ratzenberger’s Made In America. The episode highlighting Wright is scheduled to debut on Wednesday, April 23 at 8:30 PM Central. For four seasons, host John Ratzenberger has traveled the country highlighting the skill level, pride and dedication that American workers use to create the products that millions have come to depend on. In the segment on Wright Medical, he travels to Arlington, Tennessee to give viewers a closer look at the company’s products and manufacturing process, as well as meet some of the great people who use their knowledge and skills to enhance the lives of others through quality orthopaedic implants. "As a company, Wright is honored to have the opportunity to highlight the efforts of our outstanding production team,” said Gary Henley, President and CEO. "Their commitment to quality and excellence is the very foundation of our success and reputation in the orthopaedic industry.” About Wright Medical Group Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information on Wright, visit www.wmt.com. About John Ratzenberger’s Made In America John Ratzenberger’s Made In America is produced for the Travel Channel by Creative Differences. For Creative Differences, Erik Nelson is the executive producer and Dave Harding is the co-executive producer. David Gerber is the executive producer for the Travel Channel. For more information on the Travel Channel and John Ratzenberger’s Made In America, visit www.travelchannel.com/TV_Shows/Made_in_America. Safe-Harbor Statement This press release contains "forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as "anticipate,” "believe,” "could,” "estimate,” "expect,” "intend,” "may,” "plan,” "predict,” "project,” "will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2007, under the heading, "Risk Factors”), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.

Nachrichten zu Wright Medical Group Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Wright Medical Group Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!